2C-DB

2C-DB, also known as 2,5-dimethoxy-4,6-dibromophenethylamine or as 6-bromo-2C-B, is a psychedelic drug of the phenethylamine and 2C families related to 2C-B.^[1] It is the 6-bromo derivative of 2C-B and the 4,6-dibromo derivative of 2,5-dimethoxyphenethylamine (2C-H).^[1] The drug has a dose range of 20 to 35 mg orally and a duration of 6 to 8 hours.^[1] For comparison, 2C-B has a dose of 12 to 24 mg and a duration of 4 to 8 hours.^[1] 2C-DB is described as having largely the same effects as 2C-B.^[1] However, it is said that the drug may have somewhat greater visual effects than 2C-B.^[1] 2C-DB was synthesized and tested by P. Rausch in the 1990s or 2000s.^[1][2] It was described in the scientific literature by Daniel Trachsel in 2013, who cited personal communication with Rausch as the source for the information.^[1]

2C-DB

Clinical data
Other names	2-Bromo-2C-B; 2,5-Dimethoxy-4,6-dibromophenethylamine; 2,4-Dibromo-3,6-dimethoxyphenethylamine
Routes of administration	Oral[1]
Drug class	Serotonergic psychedelic; Hallucinogen
ATC code	None
Pharmacokinetic data
Duration of action	6–8 hours[1]
Identifiers
IUPAC name 2-(2,4-dibromo-3,6-dimethoxyphenyl)ethan-1-amine
Chemical and physical data
Formula	C10H13Br2NO2
Molar mass	339.027 g·mol−1
3D model (JSmol)	Interactive image
SMILES NCCc1c(OC)cc(c(c1Br)OC)Br
InChI InChI=1S/C10H13Br2NO2/c1-14-8-5-7(11)10(15-2)9(12)6(8)3-4-13/h5H,3-4,13H2,1-2H3 Key:ISCLQOQPPGRPTK-UHFFFAOYSA-N

See also

• 2C (psychedelics)
• DODB
• DODC
• 2-Bromomescaline
• 2-Bromo-TMA